Literature DB >> 17031605

Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence.

Lujiang Yuan1, Dawei Tu, Xiaoli Ye, Jianping Wu.   

Abstract

Hypocholesterolemic and hypoglycemic activities of Coptis chinensis franch inflorescence (Coptis inflorescence) were studied using animal models. Serum total and LDL cholesterol of rats fed a diet containing 1% cholesterol and 0.5% cholic acid increased, as compared with those of rats fed a normal diet. The level of total and LDL cholesterol were reduced markedly in a dose dependent manner, in rats given Coptis inflorescence extract orally at doses of 0.25, 0.5 g/kg.day for 4 weeks. In diabetic rats induced by alloxan, Coptis inflorescence extract showed a significant (p < 0.05) blood sugar lowering activity at all experimented doses (0.125, 0.25 and 0.5 g/kg.day). The highest reduction of blood sugar was about 58% when the rats were given Coptis inflorescence extract orally at a dose of 0.5 g/kg.day for 3 weeks. The 100 g dried water extract of Coptis inflorescence contained 8.11 g total alkaloid, 3.34 g berberin, 1.08 g palmatine and 0.66 g jatrorrhizine, which had long been identified as active compounds in Coptis chinensis franch root (Coptis root). Thus, the results suggest that Coptis inflorescence would be effective in the prevention and management of coronary artery disease by lowering serum cholesterol and blood sugar.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031605     DOI: 10.1007/s11130-006-0023-7

Source DB:  PubMed          Journal:  Plant Foods Hum Nutr        ISSN: 0921-9668            Impact factor:   3.921


  22 in total

1.  High cholesterol diet down regulates the activity of activator protein-1 but not nuclear factor-kappa B in rabbit brain.

Authors:  J Kálmán; B J Kudchodkar; R Krishnamoorthy; L Dory; A G Lacko; N Agarwal
Journal:  Life Sci       Date:  2001-02-16       Impact factor: 5.037

2.  Anti-inflammatory effect of berberine in rats injected locally with cholera toxin.

Authors:  M H Akhter; M Sabir; N K Bhide
Journal:  Indian J Med Res       Date:  1977-01       Impact factor: 2.375

Review 3.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

4.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Authors:  Weijia Kong; Jing Wei; Parveen Abidi; Meihong Lin; Satoru Inaba; Cong Li; Yanling Wang; Zizheng Wang; Shuyi Si; Huaining Pan; Shukui Wang; Jingdan Wu; Yue Wang; Zhuorong Li; Jingwen Liu; Jian-Dong Jiang
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

5.  Precipitation methods for the determination of LDL-cholesterol.

Authors:  L Kerscher; S Schiefer; B Draeger; J Maier; J Ziegenhorn
Journal:  Clin Biochem       Date:  1985-04       Impact factor: 3.281

6.  Berberine inhibits HIF-1alpha expression via enhanced proteolysis.

Authors:  Shankung Lin; Shiow-Chwen Tsai; Chun-Chung Lee; Bao-Wei Wang; Jer-Young Liou; Kou-Gi Shyu
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

7.  The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption.

Authors:  Guo-Yu Pan; Zhi-Jiang Huang; Guang-Ji Wang; J Paul Fawcett; Xiao-Dong Liu; Xiao-Chen Zhao; Jian-Guo Sun; Yuan-Yuan Xie
Journal:  Planta Med       Date:  2003-07       Impact factor: 3.352

8.  Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum.

Authors:  C S Tsai; R F Ochillo
Journal:  Arch Int Pharmacodyn Ther       Date:  1991 Mar-Apr

Review 9.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Authors:  J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

10.  Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.

Authors:  San-hua Leng; Fu-er Lu; Li-jun Xu
Journal:  Acta Pharmacol Sin       Date:  2004-04       Impact factor: 6.150

View more
  14 in total

1.  In vitro and in vivo antioxidant properties of extracts from Coptis chinensis inflorescence.

Authors:  Xiaoquan Ban; Bo Huang; Jingsheng He; Yuxin Chen; Hong Zeng; Li Han; Youwei Wang
Journal:  Plant Foods Hum Nutr       Date:  2011-06       Impact factor: 3.921

2.  Coptisine Prevented IL-β-Induced Expression of Inflammatory Mediators in Chondrocytes.

Authors:  Kai Zhou; Li Hu; Wenjun Liao; Defeng Yin; Feng Rui
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

3.  New perspectives on chinese herbal medicine (zhong-yao) research and development.

Authors:  Si-Yuan Pan; Si-Bao Chen; Hong-Guang Dong; Zhi-Ling Yu; Ji-Cui Dong; Zhi-Xian Long; Wang-Fun Fong; Yi-Fan Han; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

4.  Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause.

Authors:  Stephen Cw Sze; Ho-Pan Cheung; Tzi-Bun Ng; Zhang-Jing Zhang; Kam-Lok Wong; Hei-Kiu Wong; Yong-Mei Hu; Christine Mn Yow; Yao Tong
Journal:  Chin Med       Date:  2011-11-02       Impact factor: 5.455

5.  Metabolic Interaction of the Active Constituents of Coptis chinensis in Human Liver Microsomes.

Authors:  Songcan Liu; Xinfeng Zhang; Furong Qiu; Ping Miao; Shujiao Shen; Leilei Zhu; Jin Zeng; Jian Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-06       Impact factor: 2.629

6.  Synthesis and antimicrobial activity of 9-o-substituted palmatine derivatives.

Authors:  Z C Li; X B Kong; W P Mai; G C Sun; S Z Zhao
Journal:  Indian J Pharm Sci       Date:  2015 Mar-Apr       Impact factor: 0.975

Review 7.  Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients.

Authors:  Jie Wang; Xingjiang Xiong; Wei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-10       Impact factor: 2.629

Review 8.  Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes Mellitus.

Authors:  Bing Pang; Xiao-Tong Yu; Qiang Zhou; Tian-Yu Zhao; Han Wang; Cheng-Juan Gu; Xiao-Lin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

Review 9.  Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders.

Authors:  Birgit Waltenberger; Andrei Mocan; Karel Šmejkal; Elke H Heiss; Atanas G Atanasov
Journal:  Molecules       Date:  2016-06-22       Impact factor: 4.411

10.  Simultaneous Determination of Eight Alkaloids in Rat Plasma by UHPLC-MS/MS after Oral Administration of Coptis deltoidea C. Y. Cheng et Hsiao and Coptis chinensis Franch.

Authors:  Lu Liu; Zhi-Bin Wang; Yang Song; Jing Yang; Li-Jun Wu; Bing-You Yang; Qiu-Hong Wang; Li-Qian Wang; Ru-Xuan Wang; Chun-Juan Yang
Journal:  Molecules       Date:  2016-07-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.